Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18.5M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
4.19M
-
Shares change
-
+1.5M
-
Total reported value, excl. options
-
$45.9M
-
Value change
-
+$15.9M
-
Number of buys
-
30
-
Number of sells
-
-10
-
Price
-
$10.97
Significant Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q4 2018
42 filings reported holding OPRX - OptimizeRx Corp - Common Stock as of Q4 2018.
OptimizeRx Corp - Common Stock (OPRX) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.19M shares
of 18.5M outstanding shares and own 22.61% of the company stock.
Largest 10 shareholders include Park West Asset Management LLC (967K shares), WOLVERINE ASSET MANAGEMENT LLC (699K shares), Vanguard Group Inc (395K shares), WASATCH ADVISORS INC (393K shares), Venator Capital Management Ltd. (228K shares), PERKINS CAPITAL MANAGEMENT INC (215K shares), Russell Investments Group, Ltd. (183K shares), Manatuck Hill Partners, LLC (150K shares), 1492 Capital Management LLC (133K shares), and AVENIR CORP (117K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.